BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Huang X, McMahon J, Huang Y. Rapamycin attenuates aggressive behavior in a rat model of pilocarpine-induced epilepsy. Neuroscience 2012;215:90-7. [PMID: 22522471 DOI: 10.1016/j.neuroscience.2012.04.011] [Cited by in Crossref: 32] [Cited by in F6Publishing: 31] [Article Influence: 3.2] [Reference Citation Analysis]
Number Citing Articles
1 Semple BD, Zamani A, Rayner G, Shultz SR, Jones NC. Affective, neurocognitive and psychosocial disorders associated with traumatic brain injury and post-traumatic epilepsy. Neurobiol Dis 2019;123:27-41. [PMID: 30059725 DOI: 10.1016/j.nbd.2018.07.018] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 7.3] [Reference Citation Analysis]
2 Canzian J, Fontana BD, Quadros VA, Müller TE, Duarte T, Rosemberg DB. Single pentylenetetrazole exposure increases aggression in adult zebrafish at different time intervals. Neuroscience Letters 2019;692:27-32. [DOI: 10.1016/j.neulet.2018.10.045] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
3 Smolensky IV, Zubareva OE, Kalemenev SV, Lavrentyeva VV, Dyomina AV, Karepanov AA, Zaitsev AV. Impairments in cognitive functions and emotional and social behaviors in a rat lithium-pilocarpine model of temporal lobe epilepsy. Behav Brain Res 2019;372:112044. [PMID: 31220488 DOI: 10.1016/j.bbr.2019.112044] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
4 Brewster AL, Lugo JN, Patil VV, Lee WL, Qian Y, Vanegas F, Anderson AE. Rapamycin reverses status epilepticus-induced memory deficits and dendritic damage. PLoS One 2013;8:e57808. [PMID: 23536771 DOI: 10.1371/journal.pone.0057808] [Cited by in Crossref: 70] [Cited by in F6Publishing: 70] [Article Influence: 7.8] [Reference Citation Analysis]
5 Talos DM, Jacobs LM, Gourmaud S, Coto CA, Sun H, Lim KC, Lucas TH, Davis KA, Martinez-Lage M, Jensen FE. Mechanistic target of rapamycin complex 1 and 2 in human temporal lobe epilepsy. Ann Neurol 2018;83:311-27. [PMID: 29331082 DOI: 10.1002/ana.25149] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 8.5] [Reference Citation Analysis]
6 Modebadze T, Morgan NH, Pérès IA, Hadid RD, Amada N, Hill C, Williams C, Stanford IM, Morris CM, Jones RS, Whalley BJ, Woodhall GL. A Low Mortality, High Morbidity Reduced Intensity Status Epilepticus (RISE) Model of Epilepsy and Epileptogenesis in the Rat. PLoS One 2016;11:e0147265. [PMID: 26909803 DOI: 10.1371/journal.pone.0147265] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
7 Zhu X, Yao Y, Yang J, Ge Q, Niu D, Liu X, Zhang C, Gan G, Zhang A, Yao H. Seizure-induced neuroinflammation contributes to ectopic neurogenesis and aggressive behavior in pilocarpine-induced status epilepticus mice. Neuropharmacology 2020;170:108044. [PMID: 32179291 DOI: 10.1016/j.neuropharm.2020.108044] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
8 Wong M. mTOR as a potential treatment target for epilepsy. Future Neurol 2012;7:537-45. [PMID: 23620711 DOI: 10.2217/fnl.12.45] [Cited by in Crossref: 17] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
9 Hadamitzky M, Herring A, Keyvani K, Doenlen R, Krügel U, Bösche K, Orlowski K, Engler H, Schedlowski M. Acute systemic rapamycin induces neurobehavioral alterations in rats. Behav Brain Res 2014;273:16-22. [PMID: 25043732 DOI: 10.1016/j.bbr.2014.06.056] [Cited by in Crossref: 27] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
10 Chong ZZ, Shang YC, Wang S, Maiese K. Shedding new light on neurodegenerative diseases through the mammalian target of rapamycin. Prog Neurobiol. 2012;99:128-148. [PMID: 22980037 DOI: 10.1016/j.pneurobio.2012.08.001] [Cited by in Crossref: 60] [Cited by in F6Publishing: 81] [Article Influence: 6.0] [Reference Citation Analysis]
11 Hodges SL, Lugo JN. Therapeutic role of targeting mTOR signaling and neuroinflammation in epilepsy. Epilepsy Research 2020;161:106282. [DOI: 10.1016/j.eplepsyres.2020.106282] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 6.0] [Reference Citation Analysis]
12 Lidster K, Jefferys JG, Blümcke I, Crunelli V, Flecknell P, Frenguelli BG, Gray WP, Kaminski R, Pitkänen A, Ragan I, Shah M, Simonato M, Trevelyan A, Volk H, Walker M, Yates N, Prescott MJ. Opportunities for improving animal welfare in rodent models of epilepsy and seizures. J Neurosci Methods 2016;260:2-25. [PMID: 26376175 DOI: 10.1016/j.jneumeth.2015.09.007] [Cited by in Crossref: 57] [Cited by in F6Publishing: 52] [Article Influence: 8.1] [Reference Citation Analysis]
13 McMahon JJ, Yu W, Yang J, Feng H, Helm M, McMahon E, Zhu X, Shin D, Huang Y. Seizure-dependent mTOR activation in 5-HT neurons promotes autism-like behaviors in mice. Neurobiol Dis 2015;73:296-306. [PMID: 25315683 DOI: 10.1016/j.nbd.2014.10.004] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
14 Mazumder AG, Patial V, Singh D. Mycophenolate mofetil contributes to downregulation of the hippocampal interleukin type 2 and 1β mediated PI3K/AKT/mTOR pathway hyperactivation and attenuates neurobehavioral comorbidities in a rat model of temporal lobe epilepsy. Brain, Behavior, and Immunity 2019;75:84-93. [DOI: 10.1016/j.bbi.2018.09.020] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
15 Nikolaienko O, Isaeva E, Levchenko V, Palygin O, Staruschenko A. Behavioral, metabolic, and renal outcomes of 1-month isolation in adolescent male Dahl salt-sensitive rats. Am J Physiol Regul Integr Comp Physiol 2020;319:R684-9. [PMID: 33052061 DOI: 10.1152/ajpregu.00236.2020] [Reference Citation Analysis]
16 Kavaye Kandeda A, Okomolo Moto FC, Mbomo Ayissi RE, Omam Omam JP, Ojong L, Ngo Bum E. Pergularia daemia hydro-ethanolic extract protects against pentylenetetrazole kindling-induced seizures, oxidative stress, and neuroinflammation in mice. J Ethnopharmacol 2021;279:114338. [PMID: 34144196 DOI: 10.1016/j.jep.2021.114338] [Reference Citation Analysis]
17 Mazumder AG, Sharma P, Patial V, Singh D. Ginkgo biloba L. attenuates spontaneous recurrent seizures and associated neurological conditions in lithium-pilocarpine rat model of temporal lobe epilepsy through inhibition of mammalian target of rapamycin pathway hyperactivation. J Ethnopharmacol 2017;204:8-17. [PMID: 28390940 DOI: 10.1016/j.jep.2017.03.060] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 4.0] [Reference Citation Analysis]
18 Maiese K. Targeting molecules to medicine with mTOR, autophagy and neurodegenerative disorders. Br J Clin Pharmacol 2016;82:1245-66. [PMID: 26469771 DOI: 10.1111/bcp.12804] [Cited by in Crossref: 82] [Cited by in F6Publishing: 97] [Article Influence: 11.7] [Reference Citation Analysis]
19 Krueger DA, Wilfong AA, Holland-Bouley K, Anderson AE, Agricola K, Tudor C, Mays M, Lopez CM, Kim MO, Franz DN. Everolimus treatment of refractory epilepsy in tuberous sclerosis complex. Ann Neurol 2013;74:679-87. [PMID: 23798472 DOI: 10.1002/ana.23960] [Cited by in Crossref: 239] [Cited by in F6Publishing: 213] [Article Influence: 26.6] [Reference Citation Analysis]
20 Liu F, Wu M, Kai J, Dong J, Zhang B, Liu L, Zhu F, Zeng LH. Effectiveness of low dose of rapamycin in preventing seizure-induced anxiety-like behaviour, cognitive impairment, and defects in neurogenesis in developing rats. Int J Neurosci 2020;130:9-18. [PMID: 29883228 DOI: 10.1080/00207454.2018.1486827] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
21 Salaka RJ, Nair KP, Annamalai K, Srikumar BN, Kutty BM, Shankaranarayana Rao BS. Enriched environment ameliorates chronic temporal lobe epilepsy-induced behavioral hyperexcitability and restores synaptic plasticity in CA3-CA1 synapses in male Wistar rats. J Neurosci Res 2021;99:1646-65. [PMID: 33713475 DOI: 10.1002/jnr.24823] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
22 Barker-Haliski M, Knox K, Zierath D, Koneval Z, Metcalf C, Wilcox KS, White HS. Development of an antiepileptogenesis drug screening platform: Effects of everolimus and phenobarbital. Epilepsia 2021;62:1677-88. [PMID: 34080183 DOI: 10.1111/epi.16955] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
23 Leite Góes Gitai D, de Andrade TG, Dos Santos YDR, Attaluri S, Shetty AK. Chronobiology of limbic seizures: Potential mechanisms and prospects of chronotherapy for mesial temporal lobe epilepsy. Neurosci Biobehav Rev 2019;98:122-34. [PMID: 30629979 DOI: 10.1016/j.neubiorev.2019.01.004] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
24 Heng K, Haney MM, Buckmaster PS. High-dose rapamycin blocks mossy fiber sprouting but not seizures in a mouse model of temporal lobe epilepsy. Epilepsia 2013;54:1535-41. [PMID: 23848506 DOI: 10.1111/epi.12246] [Cited by in Crossref: 68] [Cited by in F6Publishing: 63] [Article Influence: 7.6] [Reference Citation Analysis]
25 Kubová H, Folbergrová J, Rejchrtová J, Tsenov G, Pařízková M, Burchfiel J, Mikulecká A, Mareš P. The Free Radical Scavenger N-Tert-Butyl-α-Phenylnitrone (PBN) Administered to Immature Rats During Status Epilepticus Alters Neurogenesis and Has Variable Effects, Both Beneficial and Detrimental, on Long-Term Outcomes. Front Cell Neurosci 2018;12:266. [PMID: 30210297 DOI: 10.3389/fncel.2018.00266] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zeyghami MA, Hesam E, Khadivar P, Hesam HK, Ahmadnia A, Amini A. Effects of atorvastatin and metformin on development of pentylenetetrazole-induced seizure in mice. Heliyon 2020;6:e03761. [PMID: 32382676 DOI: 10.1016/j.heliyon.2020.e03761] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
27 Peng WF, Fan F, Li X, Zhang QQ, Ding J, Wang X. Different behavioral and pathological changes between epilepsy-associated depression and primary depression models. Epilepsy Behav 2018;83:212-8. [PMID: 29678455 DOI: 10.1016/j.yebeh.2017.12.038] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
28 Hadamitzky M, Herring A, Kirchhof J, Bendix I, Haight MJ, Keyvani K, Lückemann L, Unteroberdörster M, Schedlowski M. Repeated Systemic Treatment with Rapamycin Affects Behavior and Amygdala Protein Expression in Rats. Int J Neuropsychopharmacol 2018;21:592-602. [PMID: 29462337 DOI: 10.1093/ijnp/pyy017] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 5.0] [Reference Citation Analysis]
29 Mehrabi S, Janahamdi M, Joghataie MT, Barati M, Marzban M, Hadjighassem M, Farahmandfar M. Blockade of p75 Neurotrophin Receptor Reverses Irritability and Anxiety-Related Behaviors in a Rat Model of Status Epilepticus. Iran Biomed J 2018;22:264-74. [PMID: 29108398 DOI: 10.22034/ibj.22.4.264] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
30 Zhu F, Kai J, Chen L, Wu M, Dong J, Wang Q, Zeng LH. Akt Inhibitor Perifosine Prevents Epileptogenesis in a Rat Model of Temporal Lobe Epilepsy. Neurosci Bull 2018;34:283-90. [PMID: 28786074 DOI: 10.1007/s12264-017-0165-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
31 Lückemann L, Unteroberdörster M, Martinez Gomez E, Schedlowski M, Hadamitzky M. Behavioral conditioning of anti-proliferative and immunosuppressive properties of the mTOR inhibitor rapamycin. Brain, Behavior, and Immunity 2019;79:326-31. [DOI: 10.1016/j.bbi.2019.04.013] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]